Drug repositioning: identifying and developing new uses for existing drugs
about
Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approachA systematic screen of FDA-approved drugs for inhibitors of biological threat agentsGenome of the human hookworm Necator americanusThe genome of the blood fluke Schistosoma mansoniTargeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityA high-throughput drug screen for Entamoeba histolytica identifies a new lead and targetEffect of nitroxoline on angiogenesis and growth of human bladder cancerChemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)'RE:fine drugs': an interactive dashboard to access drug repurposing opportunitiesValidating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortalityA Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersDrug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric DisordersMethods for biological data integration: perspectives and challengesLinked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatmentsDrug repurposing and human parasitic protozoan diseasesRecent developments in drug discovery for leishmaniasis and human African trypanosomiasisDrug repositioning approaches for the discovery of new therapeutics for Alzheimer's diseaseShifting from the single to the multitarget paradigm in drug discoveryDrug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screeningRepositioning Clofazimine as a Macrophage-Targeting Photoacoustic Contrast Agent.ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics, Phylogenetic and Therapeutic AnalysisA ranking method for the concurrent learning of compounds with various activity profiles.Forces influencing generic drug development in the United States: a narrative reviewOn metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancerCell-Based Assay Design for High-Content Screening of Drug CandidatesRepositioning of Thiourea-Containing Drugs as Tyrosinase InhibitorsThe Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung CancerTodralazine protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansionCombined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemiaDrug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitorsLiterature mining for the discovery of hidden connections between drugs, genes and diseasesAdvancing drug innovation for neglected diseases-criteria for lead progressionA computational approach to finding novel targets for existing drugsDrug discovery for Duchenne muscular dystrophy via utrophin promoter activation screeningExploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case studySystematic drug repositioning based on clinical side-effectsAssessing drug target association using semantic linked dataPrediction of chemical-protein interactions network with weighted network-based inference methodIdentifying novel drug indications through automated reasoningCDA: combinatorial drug discovery using transcriptional response modules
P2860
Q21133651-C2C94AFE-D0D0-44EE-A14C-295374A2BDF1Q21559667-CA084A64-6B72-433A-A341-BB3F151272B5Q22122067-54F65FE2-503B-4636-8594-D8811A5AFF6CQ22122228-EE519B24-7EBA-4D53-8F9B-BE2A44CA2D70Q24605869-14687859-29E2-4A1F-9863-13736FC02953Q24623736-69DF310D-66EF-4F27-8BFD-B7261CB91438Q24629326-06D51EEB-1653-40D0-8A89-342E2E2BAE52Q24634179-9458E9A0-88F0-4648-89FB-2ED7EDD25999Q24745976-5533354E-D2FC-46BA-82A2-7BEB0A7CD56BQ24745996-9119A9E5-927D-4CE1-98F3-C654DF0717D5Q26739665-9C79A6A9-59C9-4859-A1C9-CEF3D4AC66B7Q26748728-BFCFF797-AFF4-4118-8799-74D99EFAAD72Q26778582-A8268C25-8250-4B18-821E-52DE4E6D46B1Q26995786-2EE08488-0205-4B8F-9374-45CF5AA9C3BAQ26999453-483F4588-965C-45D0-8A5B-F661EB774AFEQ27011766-98819D65-ABCB-41D3-A6ED-EBA36C414F1BQ27024122-9783D8EF-EBFC-46DD-B92E-77CEE4DE88AEQ27144242-7285116D-189B-4231-BB97-0025C0482F4FQ27306843-0CF9A848-B784-435D-A533-39C6EC4CC612Q27327281-EEF71DFF-E6FC-4093-AC17-D10E90FCA89AQ27468686-2E48B8D8-48FE-4B41-B24C-C23DFA87E122Q27902271-98D7F6BE-200F-4DD7-A28C-9FB156115193Q28070306-648FBD07-E63D-4FC8-9322-46856380F67BQ28072798-59EC95E4-846C-4460-A8C0-E3521093A2FDQ28084264-256251AF-0979-4908-914D-B487B1BB67D1Q28270604-E59DB4AF-9271-4F3F-9ADB-0C538672BA40Q28395836-500ED21F-151A-44E3-9ABB-5DE9F8196DD9Q28468674-703E3C39-9C8B-415B-9DB4-FB6C8F8F3C55Q28472176-F2182259-5E98-4FE6-B1A7-1512E9BA6F75Q28475474-77EE4778-C5D3-4F1A-AF50-3EAF9B480EABQ28475561-263EAE8D-C2ED-4C73-9987-EEA108106855Q28475996-4861E341-EBD5-4678-A813-4515413816C5Q28476770-F28C2171-5A6F-41E0-80B4-E71B3D61030CQ28477551-DB654662-464E-4763-9B74-43BDF7FAD777Q28477582-9C471FCA-C3E8-45E3-AD38-64FE52D22CF7Q28478506-7B369C0F-056C-40C7-A1B1-52E164AE2C0CQ28480992-F7E1EBA7-E9E3-4C69-B02A-6CA63F50CFF2Q28481329-34F49D59-2480-4A88-B452-85C56E737175Q28481461-49B960EC-F9E4-4300-BD82-8B7E3947C9D5Q28482122-AFE1DBB3-6FA4-4FBC-BE2A-3428919C8B5B
P2860
Drug repositioning: identifying and developing new uses for existing drugs
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Drug repositioning: identifying and developing new uses for existing drugs
@ast
Drug repositioning: identifying and developing new uses for existing drugs
@en
type
label
Drug repositioning: identifying and developing new uses for existing drugs
@ast
Drug repositioning: identifying and developing new uses for existing drugs
@en
prefLabel
Drug repositioning: identifying and developing new uses for existing drugs
@ast
Drug repositioning: identifying and developing new uses for existing drugs
@en
P3181
P356
P1476
Drug repositioning: identifying and developing new uses for existing drugs
@en
P2093
P2888
P304
P3181
P356
10.1038/NRD1468
P407
P577
2004-08-01T00:00:00Z
P5875
P6179
1010423625